Drug
Bgb 16673
Bgb 16673: highest development phase Phase 1, developed by BeiGene. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- BeiGene
Trials
| Drug | Phase | Indication |
|---|---|---|
| BGB-16673 NCT06906809 | Phase 1 | Healthy Volunteers |
Latest
No recent events.
Follow Bgb 16673 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.